Mesantoin in the Treatment of Epilepsy
- 4 February 1954
- journal article
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 250 (5), 197-199
- https://doi.org/10.1056/nejm195402042500504
Abstract
IN 1950 we reviewed the literature on the serious side effects of anticonvulsants1 and described 11 cases of cytopenia attributed to Mesantoin. Six of the patients treated had died. Since our review, 2 accounts2 , 3 of similar cases, as well as other relevant articles,4 5 6 7 have appeared.The article1 referred to described general safeguards and advocated a routine supervision of blood counts that, it was hoped, would largely prevent such catastrophes. This routine, as we have followed it since then, entails a white-cell count and a differential count with a calculation of the number of neutrophils to be done at the following . . .Keywords
This publication has 5 references indexed in Scilit:
- APLASIA OF THE BONE MARROW DURING MESANTOIN® THERAPYJAMA, 1951
- MESANTOIN® IN THE MANAGEMENT OF THE HOSPITALIZED PSYCHOTIC EPILEPTICSouthern Medical Journal, 1951
- COMPARATIVE RESULTS IN SEIZURE CONTROL USING PHENOBARBITAL, DILANTIN, AND MESANTOINAmerican Journal of Psychiatry, 1950
- MESANTOIN® IN EPILEPSYJAMA, 1950
- The Serious Side Effects of the Newer Antiepileptic Drugs: Their Control and PreventionNew England Journal of Medicine, 1950